Stock Track | GENSCRIPT BIO Plummets 5.54% Intraday on Profit-Taking After ASCO Rally and Sector Weakness

Stock Track
05/28

GENSCRIPT BIO's stock price plummeted 5.54% during intraday trading on Thursday, marking a significant reversal from its previous session's gains.

The decline appears to be driven by profit-taking activity following a rally in the prior session, which was catalyzed by positive research results from its associate company Legend Biotech at the ASCO annual meeting. Additionally, concerns over institutional selling have emerged, with Hong Kong Stock Connect channels experiencing consecutive days of significant net outflows prior to this session.

Broad weakness across the Life Sciences Tools & Services sector further pressured sentiment, with multiple major players in the space also trading lower during the session, contributing to the overall downward movement in GENSCRIPT BIO's share price.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10